Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study
TMCAPTURE
1 other identifier
observational
106
1 country
1
Brief Summary
Patients and families are invited to participate in an online registry and data repository specifically for patients with transverse myelitis (TM) or acute flaccid myelitis (AFM). The data generated in this study will come from surveys, interviews, review of medical records. Data from this study will be utilized to guide future clinical trials for children with an acute case of TM or AFM. Parents and school aged children will complete an online survey 7 banks of questions. Each bundle of survey topics have 7-10 questions. We will have both the parent and child complete a outcomes based survey within 6 months of diagnosis and invite to participate every 4 months until study end in 2024.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedFirst Submitted
Initial submission to the registry
May 19, 2014
CompletedFirst Posted
Study publicly available on registry
May 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 19, 2022
CompletedAugust 23, 2022
August 1, 2022
8.3 years
May 19, 2014
August 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient and parent reported symptoms of recovery
each parent /guardian and child will fill out a questionnaire examining how you feel about your ability to move and your emotions. This is completed at 3,6,and 12 months after symptoms are diagnosed.
up to one year post symptom onset
Secondary Outcomes (1)
ASIA scale
up to one year after symptom diagnosis
Study Arms (1)
myelitis, transverse or acute flaccid myelitis
Observational study with online survey participation highlighting outcomes recovery. The surveys can be completed by the child and parent, or if too young to participate, parent only. The survey asks how the child is doing after hospitalization within 6 months of diagnosis, and every 4 months until study end in 2024.
Eligibility Criteria
Pediatric Transverse Myelitis. Pediatric Acute Flaccid Myelitis. The diagnosis of TM or AFM needs to be within 6 months of symptom onset at the time of consent.
You may qualify if:
- Diagnosis of transverse myelitis (TM) or acute flaccid myelitis (AFM)
- Patient is within 6 months of symptom onset
- Ability of patent or legal guardian is able to provide informed consent
- Ability of a child 10 or older able to provide assent
- Access to the internet
You may not qualify if:
- Inability to provide appropriate consent or assent
- Diagnosis of multiple sclerosis, neuromyelitis optica, or neuromyelitis optica spectrum disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UTexasSouthwestern
Dallas, Texas, 75235, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Greenberg, MD
UT Southwestern
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
May 19, 2014
First Posted
May 22, 2014
Study Start
May 1, 2014
Primary Completion
August 19, 2022
Study Completion
August 19, 2022
Last Updated
August 23, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share